Renalytix - Common Stock Net 2020-2024 | RNLXY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Renalytix - common stock net from 2020 to 2024. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Renalytix - common stock net from 2020 to 2024. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$45.9B
Tempus AI (TEM)	$12.8B
Doximity (DOCS)	$12.2B
Hims & Hers Health (HIMS)	$10.4B
IRhythm Technologies (IRTC)	$5.2B
Hinge Health (HNGE)	$4.6B
Privia Health (PRVA)	$2.6B
Inspire Medical Systems (INSP)	$2.6B
Heartflow (HTFL)	$2.5B
Phreesia (PHR)	$1.7B
Enovis (ENOV)	$1.7B
10x Genomics (TXG)	$1.7B
Omnicell (OMCL)	$1.5B
Schrodinger (SDGR)	$1.4B
Azenta (AZTA)	$1.4B
Clover Health Investments (CLOV)	$1.4B
Claritev (CTEV)	$1.2B
Evolent Health (EVH)	$1.1B
Fulgent Genetics (FLGT)	$651M
Veradigm (MDRX)	$498M
Zepp Health (ZEPP)	$491M
Standard BioTools (LAB)	$467M
Talkspace (TALK)	$429M
Carlsmed (CARL)	$360M
Butterfly Network (BFLY)	$360M
TruBridge (TBRG)	$289M
Outset Medical (OM)	$236M
SOPHiA GENETICS SA (SOPH)	$235M
Nyxoah SA (NYXH)	$212M
Health Catalyst (HCAT)	$205M